zelenectide pevedotin (BT8009) / Bicycle Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zelenectide pevedotin (BT8009) / Bicycle Therap
Duravelo-2, NCT06225596: Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer

Recruiting
2/3
956
Europe, Canada, US, RoW
BT8009, Pembrolizumab, Gemcitabine + cisplatin Or carboplatin, Avelumab
BicycleTx Limited
Metastatic Urothelial Cancer
12/30
12/30
Duravelo-1, NCT04561362 / 2020-002719-23: Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting
1/2
329
Europe, Canada, US
BT8009, Pembrolizumab, Keytruda
BicycleTx Limited
Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms, Breast Neoplasms, Non-Small-Cell Lung Neoplasms, Ovarian Neoplasm, Advanced Solid Tumor
12/26
12/26

Download Options